USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: RXBIO, INC.
Address: 1325 SUNSET DR
JOHNSON CITY, TN 37604-3619
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $391,936.00 3

Award List:

LPA Receptor Modulators as Radioprotectants

Award Year / Program / Phase: 2007 / SBIR / Phase I
Agency: HHS
Principal Investigator: Veeresa Gududuru
Award Amount: $97,162.00
Abstract:
DESCRIPTION (provided by applicant): The goal of this Phase I proposal is to perform lead optimization of a novel small molecular radioprotectant based on the Rx100 scaffold. Rx100, a metabolically stabilized analog of phospholipid growth factor lysophosph atidic acid (LPA), has shown promising… More

Development of an LPA receptor modulator Rx100 as a radioprotectant

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $99,977.00
Abstract:
DESCRIPTION (provided by applicant): Bone marrow and gastrointestinal mucosa are highly sensitive to radiation exposure. Radiation-induced damage to bone marrow and the gastrointestinal tract could be lethal in events such as nuclear accidents or radiation terrorism, depending on radiation doses,… More

TAS::75 0849::TAS

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Wenlin Deng – 423-928-3330
Award Amount: $194,797.00
Abstract:
No satisfactory medical interventions for radiation enteritis are available yet. We have demonstrated that polyamine inhibition by a-difluoromethylornithine orDFMO, a selective and irreversible inhibitor of ornithine decarboxylase (ODC, the primary rate-limiting enzyme in the production of… More